Pavithraa Suresh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pavithraa Suresh has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Aman Suresh Tharayil
Dr. M.G.R. Educational and Research Institute, India
1 shared publication - Indushekar Manjunatha
Northeastern University, USA
1 shared publication Priya Katiyar
Sandip Foundation's Sandip Institute of Pharmaceutical Sciences, India
1 shared publication
Latest Publications
- 14 December 2026
- Published by IGI Global Scientific Publishing
- p. 145-174
Biomarkers, Multi-Omics, and Artificial Intelligence in Vitiligo
This chapter reviews biological biomarkers, routine laboratory indicators, and emerging artificial intelligence (AI) applications in vitiligo. While advances in pathogenesis have clarified genetic, oxidative, and autoimmune mechanisms, disease heterogeneity continues to limit the clinical utility of single candidate markers. To address these challenges, the text examines how integrating multi-omics datasets with machine learning algorithms can uncover robust predictive biomarker signatures. In addition, computational tools are highlighted for objective lesion detection, automated severity assessment (Auto-VASI), and longitudinal monitoring, as well as explainable AI approaches that enhance algorithmic transparency. Overcoming key barriers—including assay standardization, diverse population cohorts, and external validation—will be essential to translate these technologies into individualized clinical decision-making and advance precision dermatology.
- 14 December 2026
- Published by IGI Global Scientific Publishing
- p. 145-174
Biomarkers, Multi-Omics, and Artificial Intelligence in Vitiligo
This chapter reviews biological biomarkers, routine laboratory indicators, and emerging artificial intelligence (AI) applications in vitiligo. While advances in pathogenesis have clarified genetic, oxidative, and autoimmune mechanisms, disease heterogeneity continues to limit the clinical utility of single candidate markers. To address these challenges, the text examines how integrating multi-omics datasets with machine learning algorithms can uncover robust predictive biomarker signatures. In addition, computational tools are highlighted for objective lesion detection, automated severity assessment (Auto-VASI), and longitudinal monitoring, as well as explainable AI approaches that enhance algorithmic transparency. Overcoming key barriers—including assay standardization, diverse population cohorts, and external validation—will be essential to translate these technologies into individualized clinical decision-making and advance precision dermatology.